Renal Cell Carcinoma News and Research

Latest Renal Cell Carcinoma News and Research

Researchers find that VEGF may not have any prognostic value for advanced prostate cancer

Researchers find that VEGF may not have any prognostic value for advanced prostate cancer

Laparoscopic radical nephropathy effective for advanced renal masses

Laparoscopic radical nephropathy effective for advanced renal masses

Study reveals a new way for detecting colorectal cancers

Study reveals a new way for detecting colorectal cancers

Study shows chemical shift MRI can help differentiate clear cell renal carcinoma from other renal cancer

Study shows chemical shift MRI can help differentiate clear cell renal carcinoma from other renal cancer

Study results show trends in surgical management of patients with kidney disease

Study results show trends in surgical management of patients with kidney disease

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Study reveals potential markers for treating patients with metastatic clear cell RCC

Study reveals potential markers for treating patients with metastatic clear cell RCC

New immunoassay appears to be valid screening method for early detection of renal cell carcinoma

New immunoassay appears to be valid screening method for early detection of renal cell carcinoma

FDA's Oncologic Drugs Advisory Committee to review NDA for tivozanib

FDA's Oncologic Drugs Advisory Committee to review NDA for tivozanib

Gene mutation findings classify renal cell carcinoma

Gene mutation findings classify renal cell carcinoma

Consortium database model compares favorably for RCC prognosis

Consortium database model compares favorably for RCC prognosis

COX-2 inhibitor extends sunitinib activity in renal cell carcinoma

COX-2 inhibitor extends sunitinib activity in renal cell carcinoma

Metastatic tumors best for sunitinib response evaluation in mRCC

Metastatic tumors best for sunitinib response evaluation in mRCC

Possible alternative to biopsy discovered for renal cancer diagnosis

Possible alternative to biopsy discovered for renal cancer diagnosis

Tivozanib overall survival results announced by AVEO and Astellas

Tivozanib overall survival results announced by AVEO and Astellas

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Metastatic renal cell carcinoma (mRCC) therapy: an interview with Charles A. Nicolette, Ph.D., CSO of Argos Therapeutics

Sunitinib does not cause lingering risks for cancer patients after their treatment ends

Sunitinib does not cause lingering risks for cancer patients after their treatment ends

Sunitinib shows promise against metastatic renal cell carcinoma

Sunitinib shows promise against metastatic renal cell carcinoma

Acceleron commences dalantercept phase 2 study in metastatic renal cell carcinoma

Acceleron commences dalantercept phase 2 study in metastatic renal cell carcinoma

Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer

Acceleron Pharma initiates dalantercept phase 2 study in advanced ovarian cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.